GlassScriptPhysician profile
Brittany Gehm
NPI 1295113934
$7,965.76
in general payments reported to CMS, 2019-2025
63 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,345 · 2022: $1,229 · 2023: $1,778 · 2024: $1,688 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,391.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $894.13 | 2021-2025 | Opdivo, Opdualag |
| Astrazeneca Pharmaceuticals LP | $794.86 | 2021-2025 | Lynparza, Enhertu, Imfinzi |
| Daiichi Sankyo INC. | $604.08 | 2021-2025 | Enhertu, Datroway |
| Novartis Pharmaceuticals Corporation | $481.91 | 2023-2025 | |
| Glaxosmithkline, LLC. | $396.75 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| Amgen INC. | $362.00 | 2021-2023 | Lumakras, Nplate, Xgeva |
| Janssen Biotech, INC. | $352.47 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Incyte Corporation | $269.87 | 2021-2025 | Jakafi |
| Eisai INC. | $269.16 | 2021-2024 | |
| Karyopharm Therapeutics INC. | $232.43 | 2021-2025 | Xpovio |
| Merck Sharp & Dohme LLC | $221.23 | 2021-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $197.32 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $185.63 | 2021-2025 | Libtayo |
| Astellas Pharma US INC | $173.51 | 2021-2025 | Padcev, Vyloy |
| Seagen INC. | $171.13 | 2021-2023 | Padcev, Adcetris, Tukysa |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Gehm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.